Meta-Analysis of Efficacy and Safety of New Oral Anticoagulants (Dabigatran, Rivaroxaban, Apixaban) Versus Warfarin in Patients With Atrial Fibrillation

Study Questions:

Are the new oral anticoagulants more effective or safer than warfarin in patients with atrial fibrillation (AF)?